controlled substances
-
How 4 Mental Health Firms Want the DEA to Handle Virtual Prescribing of Controlled Substances
Talkiatry, Array Behavioral Care, Iris Telehealth and Quartet Health sent a letter to the DEA asking for a special registration process that would allow for the prescribing of certain controlled medications via telemedicine.
-
Telehealth Companies Applaud DEA for Delaying Telemedicine Restrictions of Controlled Substances
The Drug Enforcement Administration received 38,000 comments on its proposed rule that would roll back Covid-19 flexibilities for the prescribing of controlled substances via telemedicine. In response, the DEA chose to temporarily extend the flexibilities, a decision telehealth companies like Bicycle Health and Mindbloom are in support of.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Providers Mostly Agree with the AMA’s Views on Controlled Substance Prescribing Via Telemedicine
The American Medical Association recently released its comments on the DEA’s proposed rules for controlled substance prescribing via telemedicine. Many telehealth providers are supportive of the organization’s recommendations, such as its suggestion to extend the timeframe patients have to refill their buprenorphine prescription after their initial supply is prescribed via telemedicine.
-
‘The Stakes Couldn’t Be Higher’: How DEA’s Proposal Will Affect Telehealth Controlled Substance Prescribing
The DEA recently released proposed rules that would require an in-person visit before a patient can receive a telehealth prescription for a controlled substance. The DEA touts the change as a way to ensure patient safety, but several telehealth advocates argue it will greatly disrupt access for those who need the drugs — especially at a time when the mental health and substance use crisis is growing.
-
US Sues Rite Aid for Ignoring Glaring ‘Red Flags’ in Opioid Prescriptions
The Department of Justice filed a lawsuit against Rite Aid, accusing the pharmacy chain of filling hundreds of thousands of opioid prescriptions that had “obvious, and often multiple, red flags.” The DOJ claimed that Rite Aid violated the Controlled Substances Act by filling unlawful prescriptions for addictive drugs, as well as the False Claims Act when the chain sought reimbursement from federal healthcare programs for these prescriptions.
-
Report: 14% of physicians drinking, using controlled substances on the job
There are high levels of substance use and dangerous mental health stigma among healthcare workers, according to a report released by addiction treatment organization APN. Its CEO said the most effective way to decrease stigma about seeking mental health treatment is to look at healthcare as inclusive of mental health.
-
Splunk and NewYork-Presbyterian join forces to fight drug diversion
Through the Splunk controlled substance monitoring platform, NewYork-Presbyterian can see if medications are being diverted for potentially illegitimate purposes, like a doctor prescribing a medication to a patient not currently in the hospital.
-
New Kit Check technology seeks to pinpoint drug theft and misuse
The company’s Individual Risk Identification Score, or IRIS, uses machine learning to help hospitals pinpoint employees who pose a high risk for drug diversion.
-
Docs at HealthEast seem to love e-prescribing for controlled drugs
Since HealthEast Care System in St. Paul, Minnesota, became the first health system in the state to go live with EPCS two years ago, clinicians have saved an aggregate of about 500 hours per month in time spent writing prescriptions for controlled drugs, CHIME attendees heard Wednesday.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Maine follows N.Y. in mandating e-prescribing of opioids
The new law will require prescribers and pharmacists to check the state’s prescription monitoring program before prescribing or dispensing a controlled drug. It also limits the strength and duration of scripts for opioids.
-
N.Y. state mandate for e-Rx of controlled substances takes effect; What’s the climate like?
The New York law is meant to cut down on prescription drug abuse and drug diversion by doctors and patients alike.
-
Vermont becomes final state to legalize e-prescribing of controlled substances
After a long battle, proponents of e-prescribing have achieved their goal of electronic prescribing of controlled substances becoming legal nationwide, as Vermont has become the last holdout to change its rules.
-
Surescripts now processes more transactions than AmEx, PayPal
More than two-thirds of the nation’s new prescriptions in 2014 were transmitted electronically over the wires of Surescripts, the healthcare connectivity network announced Tuesday. In all, Surescrips processed 6.5 billion healthcare data transactions last year, more than the 6 billion processed by American Express and the 4.5 billion carried over the PayPal network.
-
Should Controlled Substances Be E-Prescribed?
For years, people have made jokes about doctors’ notorious bad handwriting. While the jokes may […]
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
